Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision indicator updated to v3.5.2; previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded revision: v3.5.0. Deleted revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the header. No changes to study content or page layout were observed.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 was added; the government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a government funding lapse notice at the top of the page and updated the page revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedThe page adds UI/metadata elements (Show glossary; Results First Posted and Last Update Posted timestamps; Revision: v3.4.0) and removes older labels (Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.